Anonymous
Guest
Anonymous
Guest
So I seem to remember that when the FDA gave the "thumbs down" to indiplon and NBI was forced to lay off nearly half of its workforce, good ol' GL said that the cuts were necessary so they could regroup and conserve enough cash to hire these people back in 3 years. So....how's that going now that it's FOUR years later and you've struck a deal with Abbott for elagolix? Flooding the job boards with open positions are we? Recruiters searching high and low for all "alumnae" to join the reunion?